Drugs / Cangpo Liujun Prescription
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06394128 | Apr 2024 → Apr 2025 | colorectal cancer, myalgic encephalomeyelitis/chronic fatigue syndrome | First People's Hospital of Hangzhou | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cangpo Liujun Prescription | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06394128 ↗ |